“Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions”. Current Pharmaceutical Research 1, no. 3 (October 17, 2025): 308–322. Accessed January 15, 2026. https://cpr.org.in/index.php/files/article/view/145.